Afuco™ Anti-Human IL2 ADCC Therapeutic Antibody (MT204), ADCC Enhanced
Anti-IL2 ADCC Enhanced Antibody (MT204) is an ADCC enhanced antibody produced by our Afuco™ platform. MT204 is a humanized IgG1 antibody specific for interleukin-2 (IL-2) of human and rhesus monkey origin. MT204 has the potential to treat a wide variety of acute and chronic inflammatory diseases, including rheumatoid arthritis, asthma, acute transplant rejection, uveitis, psoriasis and multiple sclerosis. MT204 is the first humanized antibody targeting soluble human and non-human primate IL-2 by a unique mode of action, and has been shown in preclinical models to have inhibitory properties.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-395CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | IL2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |